Medway Community Healthcare Medway NHS Trust Foundation Trust
Medway Clinical Commissioning Group Swale Clinical Commissioning Group

3. Respiratory system - guidance

To access BNF Formulary section click on the link under BNF Section/s

To access the Guidance Document click on the highlighted text under the Title column

Use documents past their review date with Caution

 

BNF Section/s Title Issuing Body  Date of Issue/Review Update Due
3.2.4 Adrenaline - Prescribing of Adrenaline Auto Injectors Kent and Medway  CCG Dec 2021 Dec 2023
3.2.4 Adrenaline auto-injectors (AAIs): new guidance and resources for safe use.

 MHRA

Drug Safety Update

Jun 2023  -
3.2.4 Adrenaline Auto-Injector Patient Video - The correct use of your Adrenaline Auto-Injector (AAI)

MHRA

Drug Safety Update

 

Jun 2023
 
3.1 Asthma - Adult Asthma Guidelines Kent and Medway ICB Aug 2023 Aug 2025
3.1 Asthma - Asthma inhaler guidelines (Paediatric <12 years) Version 2 Kent and Medway ICB Dec 2023 Dec 2025
3.1 COPD - Primary Care Management of COPD Kent and Medway CCG Feb 2022 Feb 2024
3.1 COPD Rescue pack - -Chronic Obstructive Pulmonary Disease Rescue Packs Guidance for Primary Healthcare Professionals.V5 Kent and Medway CCG Dec 2023
Nov 2025
3.1 COPD Self-Management of Flare-ups Guide

Kent and Medway ICB

Feb 2022 -
3.2.3 Palforzia for treating peanut allergy in children and young people TA 769                                                                                           Not for prescribing within Kent and Medway                                   

NICE   

Feb 2022   -
3.4 Pholcodine-containing cough and cold medicines: withdrawal from UK market as a precautionary measure

MHRA

Drug Safety Update

Mar 2023  -
3.1 Pressurised metered dose inhalers (pMDI): risk of airway obstruction from aspiration of loose objects

 MHRA

Drug Safety Update

 Jul 2018  -

 

 

 

  • First Line Choice
  • On Formulary
  • Specialist Initiation Only
  • Hospital Only
  • KMPT Initiation Only
  •